Eriko Sato¹, Noriyoshi Iriyama², Michihide Tokuhira³, Tomoiku Takaku⁴, Maho Ishikawa⁵, Tomonori Nakazato⁶, Keiji Sugimoto⁷, Hiroyuki Fujita⁸, Yuta Kimura³, Isao Fujioka⁴, Norio Asou⁵, Norio Komatsu⁴, Masahiro Kizaki³, Yoshihiro Hatta², Tatsuya Kawaguchi^9,10 (1.Hematol., Juntendo Univ. Nerima Hosp., Tokyo, Japan, 2.Hematol and Rheumatol, Nihon University School of Medicine, Tokyo, Japan, 3.Hematol., Saitama Medical Center, Saitama Medical University, Saitama, Japan, 4.Hematol., Juntendo University School of Medicine, Tokyo, Japan, 5.Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan, 6.Hematol, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 7.Hematol., Juntendo University Urayasu Hospital, Urayasu, Japan, 8.Hematol., Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 9.Hematol. and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan, 10.Kumamoto Health Science University, Kumamoto, Japan)

Tomoko Yoshioka¹, Naoto Takahashi¹, Masahiro Kizaki², Tatsuya Kawaguchi³, Ritsuro Suzuki⁴, Kazuhito Yamamoto⁵, Kazunori Ohnishi⁶, Tomoki Naoe⁷, Itaru Matsumura⁸ (1.Hematol., Nephrol., and Rheumatol., Akita Univ., Akita, Japan, 2.Hematol., Saitama Medical Center, Saitama Medical Univ., Saitama, Japan, 3.Medical Technol., Kumamoto Health Science Univ., Kumamoto, Japan, 4.Oncol. and Hematol., Shimane Univ. Hospital, Izumo, Japan, 5.Hematol. and Cell Therapy, Aichi Cancer Center, Nagoya, Japan, 6.Tokai-Hokuriku Block Blood Center, Seto, Japan, 7.Nagoya Medical Center, Nagoya, Japan, 8.Hematol. and Rheumatol., Kindai Univ., Osaka-Sayama, Japan)

Kazuhito Yamamoto¹, Naoto Takahashi², Junichiro Yuda³, Masahiro Kizaki⁴, Tatsuya Kawaguchi⁵, Ritsuro Suzuki⁶, Kazunori Ohnishi⁷, Tomoki Naoe⁸, Itaru Matsumura⁹ (1.Hematol. Cell Therapy, Aichi Cancer Ctr., Nagoya, Japan, 2.Hematol. Nephrol. Rheumatol., Akita Univ., Akita, Japan, 3.Hematol., National Cancer Ctr. Hosp. East, Kashiwa, Japan, 4.Hematol., Saitama Med. Ctr., Saitama Med. Univ., Saitama, Japan, 5.Med. Technol., Kumamoto Health Science Univ., Kumamoto, Japan, 6.Oncol. Hematol., Shimane Univ. Hosp., Izumo, Japan, 7.Japanese Red Cross Tokai-Hokuriku Block Blood Ctr., Seto, Japan, 8.NHO Nagoya Med. Ctr., Nagoya, Japan, 9.Hematol. Rheumatol., Kindai Univ. Osaka-Sayama, Japan)

Takaaki Ono¹, Naoto Takahashi², Masahiro Kizaki², Tatsuya Kawaguchi², Ritsuro Suzuki², Kazuhito Yamamoto², Kazunori Ohnishi², Tomoki Naoe², Itaru Matsumura² (1.Division of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan, 2.The Japanese Society of Hematology, New TARGET Study Committee)

Takaaki Ono¹, Naoto Takahashi², Masahiro Kizaki², Tatsuya Kawaguchi², Ritsuro Suzuki², Kazuhito Yamamoto², Kazunori Ohnishi², Tomoki Naoe², Itaru Matsumura² (1.Division of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan, 2.The Japanese Society of Hematology, New TARGET Study Committee)

Yuriko Fujita¹, Tomonori Nakazato¹, Noriyoshi Iriyama², Michihide Tokuhira³, Maho Ishikawa⁴, Eriko Sato⁵, Tomoiku Takaku⁶, Keiji Sugimoto⁷, Hiroyuki Fujita⁸, Isao Fujioka⁶, Yuta Kimura³, Norio Komatsu⁶, Norio Asou⁴, Masahiro Kizaki³, Yoshihiro Hatta², Tatsuya Kawaguchi⁹ (1.Hematol, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 2.Department of Medicine, Nihon University School of Medicine, Tokyo, Japan, 3.Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, 4.Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan, 5.Hematology, Juntendo University Nerima Hospital, Tokyo, Japan, 6.Hematology, Juntendo University School of Medicine, Tokyo, Japan, 7.Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan, 8.Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 9.Medical Technology, Kumamoto Health Science University, Kumamoto, Japan)